Primary Biliary Cholangitis clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
open to eligible people ages 18-80
This is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the efficacy, safety and impact on health-related quality of life of linerixibat compared with placebo.
San Francisco, California and other locations
Our lead scientists for Primary Biliary Cholangitis research studies include Monika Sarkar.
Last updated: